- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02781233
A Progressive Resistance Training Program in Patients With Haemophilia
The Impact of Progressive Resistance Training on Quality of Life in Patients With Haemophilia
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Valencia, Spania, 46010
- University of Valencia
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- diagnosis of haemophilia A or B
- willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations
- approval by their hematologist to participate in the exercise program
- age between 18 and 60 years
- informed consent signed.
Exclusion Criteria:
- the inability to attend exercise sessions at least twice a week for 6 consecutive weeks
- non adherence to instruction on proper exercise technique
- surgical procedures performed 6 weeks prior to or during the exercise program
- participation in any other form of exercise, including rehabilitation, during the study; (5) changes in medication during the study
- a major bleeding episode that posed a risk or prevented exercise
- History of FVIII inhibitor (titer ≥ 0.6 BU [Bethesda unit]) or detectable FVIII inhibitors at screening (titer ≥ 0.4 BU)
- Another haemostatic defect
- Need for major surgery
- Withdrawal of informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Training group
Each subject will participate in 2 sessions each week during 8 weeks, with 3 days of difference (rest) between the sessions.
|
Progressive resistance training program
|
|
Placebo komparator: Control group
Usual daily activities
|
Usual daily activities
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Muscle strength
Tidsramme: baseline and 8 weeks
|
For measuring the isometric knee flexion and extension, ankle plantarflexion and dorsiflexion strength and isometric elbow flexion and extension strength, a portable hand-held dynamometer will be used (Nicholas Manual Muscle Tester, Lafayette Instruments, Indiana, USA).
|
baseline and 8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Timed Up and Go
Tidsramme: baseline and 8 weeks
|
The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. |
baseline and 8 weeks
|
|
Change in Haemophilia Quality of life questionnaire (A36 Haemophilia-QoL® )
Tidsramme: baseline and 8 weeks
|
The Haemophilia-QoL questionnaire is a self-report modular instrument that assesses nine relevant HRQoL domains for patients with haemophilia (e.g.
physical health, daily activities, joint damage, pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health, relationships and social activity).
|
baseline and 8 weeks
|
|
Change in Bleedings
Tidsramme: daily (during the 8 weeks of intervention)
|
Number of Bleedings During the study
|
daily (during the 8 weeks of intervention)
|
|
Change in viscoelastic properties (rectus femoris)
Tidsramme: baseline and 8 weeks
|
Myoton Pro
|
baseline and 8 weeks
|
|
Change in sit-to-stand test
Tidsramme: baseline and 8 weeks
|
The time taken for the participant to stand up and sit down from a standard 45 cm chair with arms three times, as quickly as possible, was measured.
|
baseline and 8 weeks
|
|
Change in Haemophilia Activities List questionnaire
Tidsramme: baseline and 8 weeks
|
The Haemophilia Activities List questionnaire measures the impact of hemophilia on self-perceived functional abilities in adults. It contains 42 multiple choice questions in seven domains: Lying/sitting/kneeling/standing (8 items) Functions of the legs (9 items) Functions of the arms (4 items) Use of transportation (3 items) Self-care (5 items) Household tasks (6 items) Leisure activities and sports (7 items) The most important outcomes are the overall sum score and three component scores relating to upper extremity activities, basic lower extremity activities, and complex lower extremity activities. A domain score for each of the seven domains can also be calculated. |
baseline and 8 weeks
|
|
Change in The Haemophilia Joint Health Score (HJHS)
Tidsramme: baseline and 8 weeks
|
The HJHS measures joint health, in the domain of body structure and function (i.e.
impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows.The HJHS 2.1 provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.
|
baseline and 8 weeks
|
|
Change in Pain
Tidsramme: baseline and 8 weeks
|
11-point numerical pain rating scale with higher score meaning higher pain
|
baseline and 8 weeks
|
|
Change in workability index
Tidsramme: baseline and 8 weeks
|
workability index with single question
|
baseline and 8 weeks
|
|
Change in analgesics use (days/week)
Tidsramme: baseline and 8 weeks
|
The number of days the participants used analgesics during the last week
|
baseline and 8 weeks
|
|
Change in Range Of Motion (ROM)
Tidsramme: baseline and 8 weeks
|
elbow extensio/flexion, ankle dorsiflexion/plantar flexion and knee flexion/extension ROM with a goniometer
|
baseline and 8 weeks
|
|
Change in Kinesiophobia
Tidsramme: baseline and 8 weeks
|
Tampa Scale of Kinesiophobia (TSK-11SV) used to assess changes in fear of movement
|
baseline and 8 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Felipe Querol-Fuentes, MD, PhD, University of Valencia
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- H15-29504
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .